LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article ; Online: Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis.

    Ma, Ann Thu / Solé, Cristina / Juanola, Adrià / Escudé, Laia / Napoleone, Laura / Avitabile, Emma / Pérez-Guasch, Martina / Carol, Marta / Pompili, Enrico / Gratacós-Ginés, Jordi / Soria, Anna / Rubio, Ana Belén / Cervera, Marta / Moreta, Maria José / Morales, Manuel / Solà, Elsa / Poch, Esteban / Fabrellas, Núria / Graupera, Isabel /
    Pose, Elisa / Ginès, Pere

    Journal of hepatology

    2024  

    Abstract: Background and aims: The management of acute kidney injury (AKI) in cirrhosis is challenging. The EASL guidelines proposed an algorithm, but this has never been validated. We aimed to prospectively evaluate this algorithm in clinical practice.: ... ...

    Abstract Background and aims: The management of acute kidney injury (AKI) in cirrhosis is challenging. The EASL guidelines proposed an algorithm, but this has never been validated. We aimed to prospectively evaluate this algorithm in clinical practice.
    Methods: Prospective cohort study of consecutive hospitalized patients with cirrhosis and AKI. EASL management algorithm includes identification/treatment of precipitating factors, 2-day albumin infusion in patients with AKI ≥ stage 1B, and treatment with terlipressin in patients with hepatorenal syndrome (HRS-AKI). Primary outcome was treatment response, which included both full and partial response. Secondary outcomes were survival and adverse events associated with terlipressin therapy.
    Results: A total of 202 AKI episodes in 139 patients were included. Overall treatment response was 80%, while renal replacement therapy was required in only 8%. Response to albumin infusion was achieved in 1/3 of episodes. Of patients not responding to albumin, most (74%) did not meet the diagnostic criteria of HRS-AKI, with ATN being the most common phenotype. Response rate in patients not meeting criteria of HRS-AKI was 70%. Only 30 patients met the diagnostic criteria HRS-AKI, and response rate to terlipressin was 61%. Median time from AKI diagnosis to terlipressin initiation was only 2.5 days. While urinary neutrophil gelatinase-associated lipocalin (uNGAL) could differentiate acute tubular necrosis (ATN) vs other phenotypes (AUROC 0.78), it did not predict response to therapy in HRS-AKI. Ninety-day transplant-free survival was negatively associated with MELD-Na, ATN and HRS-AKI as well as uNGAL. Three patients treated with terlipressin developed pulmonary edema.
    Conclusions: The application of the EASL AKI algorithm is associated with very good response rates and does not significantly delay initiation of terlipressin therapy.
    Language English
    Publishing date 2024-03-11
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 605953-3
    ISSN 1600-0641 ; 0168-8278
    ISSN (online) 1600-0641
    ISSN 0168-8278
    DOI 10.1016/j.jhep.2024.03.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Patterns of kidney dysfunction in acute-on-chronic liver failure: Relationship with kidney and patients' outcome.

    Napoleone, Laura / Solé, Cristina / Juanola, Adrià / Ma, Ann T / Carol, Marta / Pérez-Guasch, Martina / Rubio, Ana-Belén / Cervera, Marta / Avitabile, Emma / Bassegoda, Octavi / Gratacós-Ginès, Jordi / Morales-Ruiz, Manuel / Fabrellas, Núria / Graupera, Isabel / Pose, Elisa / Crespo, Gonzalo / Solà, Elsa / Ginès, Pere

    Hepatology communications

    2022  Volume 6, Issue 8, Page(s) 2121–2131

    Abstract: Impairment of kidney function is common in acute-on-chronic liver failure (ACLF). Patterns of kidney dysfunction and their impact on kidney and patient outcomes are ill-defined. Aims of the current study were to investigate patterns of kidney dysfunction ...

    Abstract Impairment of kidney function is common in acute-on-chronic liver failure (ACLF). Patterns of kidney dysfunction and their impact on kidney and patient outcomes are ill-defined. Aims of the current study were to investigate patterns of kidney dysfunction and their impact on kidney and patient outcomes in patients with acute decompensation (AD) of cirrhosis, with or without ACLF. This prospective study includes 639 admissions for AD (232 with ACLF; 407 without) in 518 patients. Data were collected at admission and during hospitalization, and patients were followed up for 3 months. Urine samples were analyzed for kidney biomarkers. Most patients with ACLF (92%) had associated acute kidney injury (AKI), in most cases without previous chronic kidney disease (CKD), whereas some had AKI-on-CKD (70% and 22%, respectively). Prevalence of AKI in patients without ACLF was 35% (p < 0.001 vs. ACLF). Frequency of CKD alone was low and similar in both groups (4% and 3%, respectively); only a few patients with ACLF (4%) had no kidney dysfunction. AKI in ACLF was associated with poor kidney and patient outcomes compared with no ACLF (AKI resolution: 54% vs. 89%; 3-month survival: 51% vs. 86%, respectively; p < 0.001 for both). Independent predictive factors of 3-month survival were Model for End-Stage Liver Disease-Sodium score, ACLF status, and urine neutrophil gelatinase-associated lipocalin (NGAL). AKI is almost universal in patients with ACLF, sometimes associated with CKD, whereas CKD alone is uncommon. Prognosis of AKI depends on ACLF status. AKI without ACLF has good prognosis. Best predictors of 3-month survival are MELD-Na, ACLF status, and urine NGAL.
    MeSH term(s) Acute Kidney Injury/diagnosis ; Acute-On-Chronic Liver Failure/diagnosis ; End Stage Liver Disease/complications ; Humans ; Lipocalin-2 ; Prospective Studies ; Renal Insufficiency, Chronic/complications ; Severity of Illness Index
    Chemical Substances Lipocalin-2
    Language English
    Publishing date 2022-05-10
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2471-254X
    ISSN (online) 2471-254X
    DOI 10.1002/hep4.1963
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Alcoholic Foamy Degeneration, an Entity Resembling Alcohol-Associated Hepatitis: Diagnosis, Prognosis, and Molecular Profiling.

    Gratacós-Ginès, Jordi / Avitabile, Emma / Montironi, Carla / Guillamon-Thiery, Alex / Hernández-Évole, Helena / Moreta, María José / Blaya, Delia / Ariño, Silvia / Rubio, Ana Belén / Pérez-Guasch, Martina / Cervera, Marta / Carol, Marta / Fabrellas, Núria / Soria, Anna / Juanola, Adrià / Graupera, Isabel / Sancho-Bru, Pau / Díaz, Alba / Coll, Mar /
    Bataller, Ramón / Ginès, Pere / Pose, Elisa

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

    2023  Volume 22, Issue 4, Page(s) 768–777.e8

    Abstract: Background & aims: Alcoholic foamy degeneration (AFD) is a condition with similar clinical presentation to alcohol-associated hepatitis (AH), but with a specific histologic pattern. Information regarding the prevalence and prognosis of AFD is scarce and ...

    Abstract Background & aims: Alcoholic foamy degeneration (AFD) is a condition with similar clinical presentation to alcohol-associated hepatitis (AH), but with a specific histologic pattern. Information regarding the prevalence and prognosis of AFD is scarce and there are no tools for a noninvasive diagnosis.
    Methods: A cohort of patients admitted to the Hospital Clinic of Barcelona for clinical suspicion of AH who underwent liver biopsy was included. Patients were classified as AFD, AH, or other findings, according to histology. Clinical features, histology, and genetic expression of liver biopsy specimens were analyzed. The accuracy of National Institute on Alcohol Abuse and Alcoholism criteria and laboratory parameters for differential diagnosis were investigated.
    Results: Of 230 patients with a suspicion of AH, 18 (8%) met histologic criteria for AFD, 184 (80%) had definite AH, and 28 (12%) had other findings. In patients with AFD, massive steatosis was more frequent and the fibrosis stage was lower. AFD was characterized by down-regulation of liver fibrosis and inflammation genes and up-regulation of lipid metabolism and mitochondrial function genes. Patients with AFD had markedly better long-term survival (100% vs 57% in AFD vs AH; P = .002) despite not receiving corticosteroid treatment, even in a model for end-stage liver disease-matched sensitivity analysis. Serum triglyceride levels had an area under the receiver operating characteristic of 0.886 (95% CI, 0.807-0.964) for the diagnosis of AFD, whereas the National Institute on Alcohol Abuse and Alcoholism criteria performed poorly. A 1-step algorithm using triglyceride levels of 225 mg/dL (sensitivity, 0.77; specificity, 0.90; and Youden index, 0.67) is proposed for differential diagnosis.
    Conclusions: AFD in the setting of suspicion of AH is not uncommon. A differential diagnosis is important because prognosis and treatment differ largely. Triglyceride levels successfully identify most patients with AFD and may be helpful in decision making.
    MeSH term(s) Humans ; End Stage Liver Disease ; Severity of Illness Index ; Hepatitis, Alcoholic/pathology ; Prognosis ; Triglycerides
    Chemical Substances Triglycerides
    Language English
    Publishing date 2023-12-06
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2119789-1
    ISSN 1542-7714 ; 1542-3565
    ISSN (online) 1542-7714
    ISSN 1542-3565
    DOI 10.1016/j.cgh.2023.11.031
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome.

    Solé, Cristina / Ma, Ann T / Solà, Elsa / Carol, Marta / Fabrellas, Núria / Juanola, Adrià / Napoleone, Laura / Gratacós-Ginès, Jordi / Bassegoda, Octavi / Cervera, Marta / Pérez, Martina / Rubio, Ana Belén / Avitabile, Emma / Morales-Ruiz, Manuel / Graupera, Isabel / Pose, Elisa / Kamath, Patrick S / Ginès, Pere

    Liver international : official journal of the International Association for the Study of the Liver

    2021  Volume 41, Issue 11, Page(s) 2729–2732

    Abstract: Whether tubular injury develops in patients with acute kidney injury owing to hepatorenal syndrome (AKI-HRS) is controversial. We performed repeated measurements of biomarkers of tubular injury during a 14-day period in 60 patients with cirrhosis and AKI ...

    Abstract Whether tubular injury develops in patients with acute kidney injury owing to hepatorenal syndrome (AKI-HRS) is controversial. We performed repeated measurements of biomarkers of tubular injury during a 14-day period in 60 patients with cirrhosis and AKI (34 with AKI-HRS meeting the classical definition of type 1 HRS and 26 with AKI owing to acute tubular necrosis, AKI-ATN). Nineteen of 34 patients had resolution of AKI-HRS, while the remainder had persistent AKI-HRS. The persistence of AKI-HRS was associated with remarkably high short-term mortality. There were no significant differences in urinary NGAL or IL-18 between patients with resolution vs those with persistent AKI-HRS throughout the 14-day period. By contrast, biomarker levels were significantly lower in AKI-HRS, even if persistent, compared to AKI-ATN. These findings are highly suggestive of lack of significant tubular injury in AKI-HRS and could be of value in the clinical decision between combined liver-kidney or liver transplantation alone in patients with cirrhosis and AKI candidates to transplantation.
    MeSH term(s) Acute Kidney Injury/diagnosis ; Biomarkers ; Hepatorenal Syndrome ; Humans ; Liver Cirrhosis/complications ; Liver Transplantation
    Chemical Substances Biomarkers
    Language English
    Publishing date 2021-10-05
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2102783-3
    ISSN 1478-3231 ; 1478-3223
    ISSN (online) 1478-3231
    ISSN 1478-3223
    DOI 10.1111/liv.15069
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.

    Juanola, Adrià / Graupera, Isabel / Elia, Chiara / Piano, Salvatore / Solé, Cristina / Carol, Marta / Pérez-Guasch, Martina / Bassegoda, Octavi / Escudé, Laia / Rubio, Ana-Belén / Cervera, Marta / Napoleone, Laura / Avitabile, Emma / Ma, Ann T / Fabrellas, Núria / Pose, Elisa / Morales-Ruiz, Manuel / Jiménez, Wladimiro / Torres, Ferran /
    Crespo, Gonzalo / Solà, Elsa / Ginès, Pere

    Journal of hepatology

    2021  Volume 76, Issue 1, Page(s) 107–114

    Abstract: Background & aims: Decompensated cirrhosis (DC) is associated with high mortality, mainly owing to the development of acute-on-chronic liver failure (ACLF). Identifying the patients with DC who are at high risk of mortality and ACLF development is an ... ...

    Abstract Background & aims: Decompensated cirrhosis (DC) is associated with high mortality, mainly owing to the development of acute-on-chronic liver failure (ACLF). Identifying the patients with DC who are at high risk of mortality and ACLF development is an unmet clinical need. Liver fatty acid-binding protein (L-FABP) is expressed in several organs and correlates with liver and systemic inflammation. Herein, we aimed to assess the prognostic value of L-FABP in patients with DC.
    Methods: A prospective series of 444 patients hospitalized for DC was divided into 2 cohorts: study cohort (305 patients) and validation cohort (139 patients). L-FABP was measured in urine and plasma samples collected at admission. Neutrophil gelatinase-associated lipocalin (NGAL) was also measured in urine samples for comparison.
    Results: Urine but not plasma L-FABP correlated with 3-month survival on univariate analysis. On multivariate analysis, urine L-FABP and model for end-stage liver disease (MELD)-Na were the only independent predictors of prognosis. Urine L-FABP levels were higher in patients with ACLF than in those without and also predicted the development of ACLF, together with MELD-Na, during follow-up. In patients with ACLF, urine L-FABP correlated with liver, coagulation, and circulatory failure. Urine L-FABP levels were also increased in patients with acute kidney injury, particularly in those with acute tubular necrosis. The ability of urinary L-FABP to predict survival and ACLF development was confirmed in the validation cohort. Urine NGAL predicted outcome on univariate but not multivariate analysis.
    Conclusions: Urinary L-FABP levels are independently associated with the 3-month clinical course in patients with DC, in terms of mortality and ACLF development. Urinary L-FABP is a promising prognostic biomarker for patients with DC.
    Lay summary: Increased levels of liver fatty acid-binding protein (L-FABP), a protein related to lipid metabolism, have been associated with liver-related diseases. The present study analyzed urinary L-FABP levels in 2 independent groups of patients with decompensated cirrhosis and showed that higher urinary L-FABP levels correlated with increased mortality and risk of acute-on-chronic liver failure development. Therefore, urinary L-FABP levels could be useful as a new tool to predict complications in patients with decompensated cirrhosis.
    Language English
    Publishing date 2021-09-13
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 605953-3
    ISSN 1600-0641 ; 0168-8278
    ISSN (online) 1600-0641
    ISSN 0168-8278
    DOI 10.1016/j.jhep.2021.08.031
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Efectos de un programa de ejercicios aeróbicos y técnicas de relajación sobre el estado de ansiedad, calidad del sueño, depresión y calidad de vida en pacientes con fibromialgia: ensayo clínico aleatorizado.

    Arcos-Carmona, Isabel María / Castro-Sánchez, Adelaida María / Matarán-Peñarrocha, Guillermo Adolfo / Gutiérrez-Rubio, Ana Belén / Ramos-González, Elena / Moreno-Lorenzo, Carmen

    Medicina clinica

    2011  Volume 137, Issue 9, Page(s) 398–401

    Abstract: Background and objective: Fibromyalgia is considered as a combination of physical, psychological and social disabilities. The purpose of the present study was to determine the benefits of aerobic exercise program and progressive relaxation techniques on ...

    Title translation Effects of aerobic exercise program and relaxation techniques on anxiety, quality of sleep, depression, and quality of life in patients with fibromyalgia: a randomized controlled trial.
    Abstract Background and objective: Fibromyalgia is considered as a combination of physical, psychological and social disabilities. The purpose of the present study was to determine the benefits of aerobic exercise program and progressive relaxation techniques on anxiety, quality of sleep, depression and quality of life in patients with fibromyalgia.
    Patients and method: An experimental study was performed with a placebo control group. Fifty-six fibromyalgia patients were randomly assigned to intervention (aerobic exercises+progressive relaxation techniques) and placebo (sham treatment with disconnected magnet therapy device) groups. Outcome measures were anxiety (STAI- State Trait Anxiety Inventory), quality of sleep (Pittsburgh sleep quality index), depression (Beck depression inventory) and quality of life (questionnaire SF-36). Measures were performed at baseline and after 10-weeks treatment.
    Results: After 10 weeks of treatment, the intervention group showed significant reduction (p<0.05) in sleep duration, trait anxiety and quality of life.
    Conclusions: The combination of aerobic exercise program and progressive relaxation techniques contribute to improve night rest, trait anxiety and quality of life in patients with fibromyalgia.
    MeSH term(s) Adult ; Anxiety/etiology ; Anxiety/therapy ; Depression/etiology ; Depression/therapy ; Exercise ; Fibromyalgia/complications ; Fibromyalgia/psychology ; Fibromyalgia/therapy ; Humans ; Middle Aged ; Quality of Life ; Relaxation Therapy ; Severity of Illness Index ; Sleep Disorders, Intrinsic/etiology ; Sleep Disorders, Intrinsic/therapy ; Surveys and Questionnaires ; Treatment Outcome
    Language Spanish
    Publishing date 2011-10-08
    Publishing country Spain
    Document type Comparative Study ; English Abstract ; Journal Article ; Randomized Controlled Trial
    ZDB-ID 411607-0
    ISSN 1578-8989 ; 0025-7753
    ISSN (online) 1578-8989
    ISSN 0025-7753
    DOI 10.1016/j.medcli.2010.09.045
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top